BIGBEAR
PHARMACEUTICAL
Pomalidomide is a third‑generation oral immunomodulatory antineoplastic agent and a derivative of thalidomide.
AuthenticGuaranteeFast DeliveryPrivacy Overview of Empliciti Triple TherapyEmpliciti is a multiple myeloma therapy developed by Bristol-Myers Squibb (BMS). The U.S. regulatory authorities h···【More】
Update: 18 Mar,2026Source: BigbearViews: 94
Approval OverviewRecently, the Committee for Medicinal Products for Human Use (CHMP) of the European Union has granted a positive opinion for the trip···【More】
Update: 18 Mar,2026Source: BigbearViews: 95
Approval AnnouncementMay 25, 2020 — Bristol-Myers Squibb (BMS) recently announced that the U.S. Food and Drug Administration (FDA) has approved Pomaly···【More】
Update: 18 Mar,2026Source: BigbearViews: 107
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
